Profits crashing for some med tech giants

Qmed has put together the 5 biggest drops in profit for med tech companies in 2014, and it's not looking good for device giants so far this year. Stryker's ($SYK) profit has plummeted by a whopping 77% over its metal-on-metal hip implant lawsuit costs, while Intuitive Surgical ($ISRG) follows next with a 76.6% drop in profit and the FDA crying foul over its power morcellators. Edwards Lifesciences' ($EW) profit is down by 53.1% because of its ongoing TAVR patent war with Medtronic ($MDT), which has brought Medtronic down by 53.8%. Finally, there's Abbott ($ABT), which has seen profits drop by 31.1%--analysts say it's because of the company's voluntary recall of baby formula in China. More

Suggested Articles

Flatiron has hired a new chief medical officer as it looks to push on under its new parent in the world of electronic health records and real-world data.

Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive cancer liquid biopsy tests.

Terumo will help Orchestra BioMed develop its sirolimus-eluting balloon in both coronary and peripheral cardiovascular interventions.